ILLUMINA MISEQDX CYSTIC FIBROSIS 139-VARIANT ASSAY— 510(k) K124006

Substantially Equivalent

Illumina, Inc.

FDA 510(k) clearance K124006 for ILLUMINA MISEQDX CYSTIC FIBROSIS 139-VARIANT ASSAY, Substantially Equivalent on 2013-11-19. Applicant: Illumina, Inc..

Clearance details

Applicant
Illumina, Inc.
Product code
Code PFR
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.